Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

Center for Heart & Vascular Health

Pulmonary Hypertension Program

Pulmonary hypertension is abnormally high blood pressure in the blood vessels in the lungs. It causes the heart to work harder than normal, and it can lead to shortness of breath, dizziness, fainting and other symptoms.

Taking care of people who have pulmonary arterial hypertension requires special expertise, from coordinating their complex medical needs to finding the best drugs to manage their breathing and heart troubles.

The Pulmonary Hypertension Program at ChristianaCare takes a multidisciplinary approach to treating this rare but serious disease. The program brings together a pulmonologist, a clinical pharmacist, a nurse practitioner, a clinical nurse specialist and a case manager to provide specialized care for adult patients. Working together, the team shapes and continually refines a plan of care suited to each person’s needs. In recent years, many new medical treatments have emerged to help patients better manage their symptoms.

When patients need to be admitted to Christiana Hospital, they get access to the state-of-the-art cardiac catheterization lab, noninvasive cardiac testing, cardiopulmonary stress testing and many other services. Our team works closely with the specially-trained staff on the hospital’s pulmonary stepdown unit to ensure continuity of care during each patient’s hospital stay.

Other program features include a monthly support group and access to new or investigational treatments through participation in industry-sponsored clinical trials.

Pulmonary Hypertension Program
Christiana Hospital, Room 1070
4755 Ogletown-Stanton Road, Newark, DE 19718 directions
302-733-1663
fax: 302-733-1616